By: Benzinga
January 24, 2013 at 09:34 AM EST
Biodel Issues Correction on Earlier Release Related to BIOD-238, BIOD-250
In a release issued earlier today by Biodel Inc. (Nasdaq: BIOD ), one reference to BIOD-238 should have been BIOD-250 in the fourth paragraph. The corrected paragraph follows: Local injection site discomfort was measured with a 100 mm visual analog scale (VAS) and patient questionnaires. 100 mm is defined as the worst possible discomfort
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here